| 13.8 0.01 (0.07%) | 05-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.21 | 1-year : | 16.35 |
| Resists | First : | 13.88 | Second : | 14 |
| Pivot price | 13.76 |
|||
| Supports | First : | 13.69 | Second : | 11.39 |
| MAs | MA(5) : | 13.78 |
MA(20) : | 13.75 |
| MA(100) : | 12.33 |
MA(250) : | 9.99 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 85.4 |
D(3) : | 84.1 |
| RSI | RSI(14): 61.6 |
|||
| 52-week | High : | 14.22 | Low : | 6.46 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ EHAB ] has closed below upper band by 7.1%. Bollinger Bands are 93% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 43 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 13.82 - 13.89 | 13.89 - 13.95 |
| Low: | 13.63 - 13.71 | 13.71 - 13.77 |
| Close: | 13.68 - 13.8 | 13.8 - 13.91 |
Enhabit, Inc. operates as a U.S.-based provider of home healthcare and hospice services. Its comprehensive home health division offers various services, such as patient education, pain management, wound care (including dressing changes), cardiac rehabilitation, infusion therapy, pharmaceutical administration, and expert observation and assessment. The company specializes in managing chronic conditions like diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and persistent pain. Additionally, Enhabit provides tailored disease-specific plans for individuals with diabetes, congestive heart failure, those recovering from orthopedic surgery or injuries, and patients with respiratory illnesses. Complementing these medical offerings, licensed physical, occupational, and speech therapists deliver vital rehabilitative support. Beyond home health, Enhabit delivers extensive hospice services designed to meet the physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. These services encompass pain and symptom control, palliative and dietary counseling, social worker visits, spiritual guidance, and bereavement support. As of March 31, 2022, Enhabit maintained a significant operational footprint, with 252 home health agencies and 99 hospice agencies spread across 34 states. Established in 2014 and headquartered in Dallas, Texas, the company was previously known as Encompass Health Home Health Holdings, Inc., officially rebranding to Enhabit, Inc. in March 2022. Enhabit, Inc. began operating as a completely independent entity on July 1, 2022.
Wed, 16 Sep 2026
EHAB Q4 2025 Earnings: EPS of $0.14 Lands Slightly Below Consensus - Earnings Manipulation Risk - careplusvn.com
Sun, 09 Aug 2026
Enhabit Inc (EHAB-N) Stock Price and News - The Globe and Mail
Fri, 15 May 2026
Enhabit Completes Previously Announced Acquisition by Kinderhook Industries to Become a Private Company - Business Wire
Thu, 16 Apr 2026
Enhabit receives HSR early termination, schedules May 12 stockholder vote; merger expected Q2 2026 - tradingview.com
Sat, 11 Apr 2026
How The Enhabit (EHAB) Story Is Shifting Toward Kinderhook’s US$13.80 Cash Deal - Yahoo Finance
Fri, 13 Mar 2026
Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with a 1.47% Potential Upside - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 51 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 3.6 (%) |
| Held by Institutions | 100.6 (%) |
| Shares Short | 1,200 (K) |
| Shares Short P.Month | 1,350 (K) |
| EPS | -0.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.52 |
| Profit Margin | -0.4 % |
| Operating Margin | 4.3 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | -0.2 % |
| Qtrly Rev. Growth | 1.8 % |
| Gross Profit (p.s.) | 10.16 |
| Sales Per Share | 20.69 |
| EBITDA (p.s.) | 1.56 |
| Qtrly Earnings Growth | 2.9 % |
| Operating Cash Flow | 88 (M) |
| Levered Free Cash Flow | 48 (M) |
| PE Ratio | -197.15 |
| PEG Ratio | 0 |
| Price to Book value | 1.31 |
| Price to Sales | 0.66 |
| Price to Cash Flow | 8.03 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|